Back to directory
Website
HEALTHCARE
Hepta
hepta.bio
Country
United States
City
San Francisco
Founded
—
Headcount
1-10
California
Description
Hepta develops liquid biopsy technology for chronic disease detection, using its AI platform LiquidTransformer to analyze epigenetic patterns in cell-free DNA. The company initially focuses on MASH (metabolic-associated steatohepatitis).
Funding history
No funding rounds tracked.
Founders
No founders identified yet.